INDSWFTLABNSEInd-Swift Laboratories Limited· PharmaceuticalsHighNeutral
Announced Wed, 10 Sept · 17:46 IST

Ind-Swift Laboratories Limited has informed the Exchange regarding 'Disclosure under Regulation 10(6)- Report to Stock Exchanges in respect of acquisition made in reliance upon exemption provided for in Regulation 10 of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 for inter-se transfer of shares between the promoters of the Company '.

Ownership Changes View source PDF

INDSWFTLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Ind-Swift Laboratories has filed a regulatory disclosure regarding a transfer of shares between members of its promoter group. Under Regulation 10 of SEBI's Takeover Regulations, such inter-se transfers between promoters are exempt from triggering an open offer to public shareholders. The total promoter shareholding in the company remains unchanged; only the distribution of shares within the promoter family/entities is being rearranged. No specific details on the quantum of shares transferred or the parties involved were disclosed in the headline.

Likely market impact

Neutral for shareholders — this is an internal reshuffle within the promoter group and does not change the overall promoter stake or introduce any new controlling entity. Typically no material impact on stock price.